奎尔素作为口腔癌的治疗剂:目前的证据和未来的方向
Hua Sun1, Huihui Wang2, Shujiang Guo3
1Oral Cavity Teaching and Research Section, Medical School, Hebi Polytechnic College, Hebi, China.
Asia-Pacific journal of clinical oncology
|November 14, 2025
概括
类固醇奎尔丁显示为口腔癌的抗癌药物具有前途,可能克服治疗耐药性并减少副作用. 需要进行进一步的临床试验,以优化其与纳米配方和其他疗法的使用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 纳米技术纳米技术
背景情况:
- 口腔状细胞癌是侵略性的,复发率高,预后不佳.
- 目前的治疗方法 (手术,化疗,放射治疗) 有严重的副作用和药物耐药性问题.
- 奎尔是一种黄类化合物,具有抗癌性质,如诱导亡和化学敏感化.
研究的目的:
- 探索奎尔丁在口腔癌管理中的治疗潜力.
- 审查氨酸输送系统和人工智能应用的进展.
- 要突出奎尔塞丁作为潜在的辅助疗法的作用.
主要方法:
- 审查关于奎尔丁抗癌机制的现有文献.
- 对纳米配方进行分析,以提高奎尔塞丁的生物可用性.
- 在预测治疗反应和识别目标方面探索人工智能.
主要成果:
- 奎尔丁显示出针对各种口腔癌的多重向潜力.
- 纳米配方增强了奎尔塞丁的稳定性,生物可用性和治疗效果.
- 人工智能提供个性化的治疗策略和目标识别.
结论:
- 奎尔对口腔癌具有显著的治疗前景,特别是作为辅助治疗.
- 优化输送系统和进行临床试验是关键的下一步.
- 将奎尔素与传统和免疫疗法结合使用,可以克服治疗障碍并降低毒性.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


